DBV Technologies (DBVT) Cash from Investing Activities Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -109.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109.10% |
| Dec 31, 2025 | -176.02% |
| Sep 30, 2025 | -53.06% |
| Jun 30, 2025 | 61.57% |
| Mar 31, 2025 | -237.27% |
| Dec 31, 2024 | 54.29% |
| Sep 30, 2024 | -58.98% |
| Jun 30, 2024 | 58.97% |
| Mar 31, 2024 | -125.88% |
| Dec 31, 2023 | 33.40% |
| Sep 30, 2023 | 25.60% |
| Jun 30, 2023 | 13.12% |
| Mar 31, 2023 | 26.93% |
| Dec 31, 2021 | 63.64% |
| Dec 31, 2020 | 59.06% |